GlassScriptPhysician profile
Lauren Stewart
NPI 1346683034
$1,585.23
in general payments reported to CMS, 2019-2025
12 companies · $52.79 in 2025
The $52.79 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $20.86 · 2021: $218 · 2022: $244 · 2023: $359 · 2024: $93.35 · 2025: $52.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $598.09 | 2019 | |
| Medtronic, INC. | $274.84 | 2021-2025 | Interstim |
| Abbvie INC. | $248.56 | 2023 | Botox |
| Axonics, INC. | $112.28 | 2021 | |
| Dentsply Ih Ab | $81.39 | 2021-2025 | Lofric, Lofric |
| Urogen Pharma, INC. | $72.52 | 2023-2024 | Jelmyto |
| Alnylam Pharmaceuticals INC. | $62.02 | 2020-2021 | |
| Dentsply Ih INC. | $41.10 | 2022 | |
| Pfizer INC. | $30.66 | 2021 | |
| Astellas Pharma US INC | $24.26 | 2023 | Myrbetriq |
| Boston Scientific Corporation | $20.74 | 2024 | Spaceoar Vue System - 10ml |
| Abc Home Medical Supply, INC. | $18.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.